Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Dare Bioscience stock (DARE)

Buy Dare Bioscience stock in 5 easy steps, view past price performance and learn what’s ahead for the company.

Dare Bioscience is a biotechnology business based in the US. Dare Bioscience shares (DARE) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $3.14 – an increase of 4.32% over the previous week. Dare Bioscience employs 23 staff and has a trailing 12-month revenue of around $2.8 million.

Our top picks for where to buy Dare Bioscience stock

Our pick for investing by theme

Go to site
  • Trade $0 commission stocks & ETFs with as little as $1
  • Earn up to $300 with qualifying deposits
  • Discover new opportunities with Opto's AI-driven thematic investing system
  • Theme and ETF screener

Our pick for stock bonuses

Go to site
  • Trade stocks, options, ETFs, mutual funds, alternative asset funds
  • $0 commission on stocks, ETFs and options with no options contract fees
  • Get up to $1,000 in stock when you fund a new account within 30 days
  • Access to a financial planner
Probability of member receiving $1,000 is 0.028%

Top pick for advanced traders

Go to site
  • Trade options, futures, options on futures, stocks, ETFs
  • $0 commission to close options
  • Pro-grade platform and risk analysis tools

How to buy Dare Bioscience stock

  1. Choose a stock trading platform. Use our comparison table
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DARE. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Dare Bioscience stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Product USFST Finder Score Available asset types Stock trade fee Minimum deposit Cash sweep APY Signup bonus
OPTO logo
Finder score
Stocks, ETFs
$0
$0
N/A
Earn up to $300
SoFi Wealth Management logo
Finder score
Stocks, Options, Mutual funds, ETFs, Alternatives
$0
$0
0.02%
Get up to $1,000 in stock
Tastytrade logo
Finder score
Stocks, Options, ETFs, Cryptocurrency, Futures, Treasury Bills
$0
$0
N/A
Get $50-$5,000
Public logo
Finder score
Stocks, Bonds, Options, ETFs, Cryptocurrency, Alternatives, Treasury Bills, High-yield cash account
$0
$0
4.1%
Get up to $10,000 and transfer fees covered
JPMorgan logo
Finder score
Mutual funds, ETFs
$0
$25,000
N/A
loading

What is the Finder Score?

The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.

We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.

Read the full Finder Score breakdown

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Dare Bioscience stock price (NASDAQ: DARE)

Use our graph to track the performance of DARE stocks over time.

Dare Bioscience shares at a glance

Information last updated 2025-02-07.
Latest market close$3.14
52-week range$2.67 - $7.56
50-day moving average $3.24
200-day moving average $3.72
Wall St. target price$21.33
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-0.58

Is it a good time to buy Dare Bioscience stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Dare Bioscience price performance over time

Historical closes compared with the close of $3.1 from 2025-02-10

1 week (2025-02-04) 0.65%
1 month (2025-01-10) -0.64%
3 months (2024-11-12) -29.71%
6 months (2024-08-12) -11.43%
1 year (2024-02-09) 790.80%
2 years (2023-02-10) -77.73%
3 years (2022-02-11) 19.92
5 years (2020-02-11) 15

Dare Bioscience financials

Revenue TTM $2.8 million
Gross profit TTM $-18,806,124
Return on assets TTM -71.42%
Return on equity TTM -994.69%
Profit margin -253.6%
Book value $-0.61
Market Capitalization $26.4 million

TTM: trailing 12 months

Dare Bioscience share dividends

We're not expecting Dare Bioscience to pay a dividend over the next 12 months.

Have Dare Bioscience's shares ever split?

Dare Bioscience's shares were split on a 1:12 basis on 30 June 2024 . So if you had owned 12 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Dare Bioscience shares – just the quantity. However, indirectly, the new 1100% higher share price could have impacted the market appetite for Dare Bioscience shares which in turn could have impacted Dare Bioscience's share price.

Dare Bioscience share price volatility

Over the last 12 months, Dare Bioscience's shares have ranged in value from as little as $2.6703 up to $7.56. A popular way to gauge a stock's volatility is its "beta".

DARE.US volatility(beta: 1.34)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Dare Bioscience's is 1.34. This would suggest that Dare Bioscience's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Dare Bioscience overview

Daré Bioscience, Inc. , a biopharmaceutical company, identifies, develops, and markets products for women's health in the United States. It develops therapies in the areas of contraception, reproductive health, menopause, fertility, and sexual and vaginal health. The company offers XACIATO for the treatment of bacterial vaginosis in female patients 12 years of age and older. It is developing Ovaprene, a hormone-free, monthly intravaginal contraceptive; Sildenafil Cream, a cream formulation of sildenafil for topical administration to the female genitalia on demand for the treatment of female sexual arousal disorder; DARE-HRT1 to treat moderate to-severe vasomotor symptoms in menopausal hormone therapy; DARE-VVA1 for the treatment of moderate-to-severe dyspareunia or pain during sexual intercourse; and DARE-CIN to treat cervical intraepithelial neoplasia and other human papillomavirus related pathologies. The company is also developing DARE-PDM1 for the treatment of primary dysmenorrhea; DARE-204 and DARE-214, an injectable formulations contraception of etonogestrel designed to provide contraception over 6-month and 12-month periods; DARE-FRT1, an intravaginal ring designed to deliver bio-identical progesterone for luteal phase support as part of an in vitro fertilization treatment plan; and DARE-PTB1 for the prevention of preterm birth. In addition, it is developing DARE-LARC1, a contraceptive implant delivering levonorgestrel with a woman-centered design that controlled contraceptive option; DARE-LBT, a novel hydrogel formulation for vaginal delivery of live biotherapeutics to support vaginal health; DARE-GML, a multi-target antimicrobial agent; DARE-RH1, a novel approach to non-hormonal contraception for men and women by targeting the CatSper ion channel; and DARE-PTB2 for the prevention and treatment of idiopathic preterm birth through inhibition of a stress response protein.

Frequently asked questions

null
What percentage of Dare Bioscience is owned by insiders or institutions?
Currently 1.592% of Dare Bioscience shares are held by insiders and 7.591% by institutions.
How many people work for Dare Bioscience?
Latest data suggests 23 work at Dare Bioscience.
When does the fiscal year end for Dare Bioscience?
Dare Bioscience's fiscal year ends in December.
Where is Dare Bioscience based?
Dare Bioscience's address is: 3655 Nobel Drive, San Diego, CA, United States, 92122
What is Dare Bioscience's ISIN number?
Dare Bioscience's international securities identification number is: US23666P1012
What is Dare Bioscience's CUSIP number?
Dare Bioscience's Committee on Uniform Securities Identification Procedures number is: 15708Q105

Ask a question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

More guides on Finder

Go to site